|
ZNF195 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.256400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.276400E-01 |
| Normal-vs-Stage2 |
3.710100E-02 |
| Normal-vs-Stage3 |
9.904000E-03 |
| Normal-vs-Stage4 |
4.763900E-03 |
| Stage1-vs-Stage2 |
1.176370E-01 |
| Stage1-vs-Stage3 |
9.597600E-03 |
| Stage1-vs-Stage4 |
7.180800E-03 |
| Stage2-vs-Stage3 |
7.192200E-01 |
| Stage2-vs-Stage4 |
6.664800E-01 |
| Stage3-vs-Stage4 |
9.603800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.078200E-02 |
| Normal-vs-AfricanAmerican |
3.789800E-02 |
| Normal-vs-Asian |
7.907800E-01 |
| Caucasian-vs-AfricanAmerican |
2.832800E-01 |
| Caucasian-vs-Asian |
2.065200E-01 |
| AfricanAmerican-vs-Asian |
9.194100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.939800E-01 |
| Normal-vs-Female |
5.186200E-02 |
| Male-vs-Female |
3.302200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.791600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.082300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.575700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.247430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.426240E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.298800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.324800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.862200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.932000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.379600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.829600E-02 |
| Classical-VS-Follicular |
4.475800E-03 |
| Classical-VS-Other |
9.193800E-01 |
| Classical-VS-Normal |
4.451000E-01 |
| Tall-VS-Follicular |
9.341000E-01 |
| Tall-VS-Other |
2.847400E-01 |
| Tall-VS-Normal |
2.791900E-02 |
| Follicular-VS-Other |
3.494800E-01 |
| Follicular-VS-Normal |
1.248310E-02 |
| Other-VS-Normal |
8.328200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.163800E-02 |
| Normal-vs-N1 |
1.990180E-01 |
| N0-vs-N1 |
4.551400E-01 |
|
|
